Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG

被引:0
|
作者
Montavon, C
Toure-Kane, C
Liegeois, F
Mpoudi, E
Bourgeois, A
Vergne, L
Perret, JL
Boumah, A
Saman, E
Mboup, S
Delaporte, E
Peeters, M
机构
[1] Inst Rech Dev, Retrovirus Lab, F-34042 Montpellier 1, France
[2] Hop Le Dantec, Microbiol Lab, Dakar, Senegal
[3] Mil Hosp, Projet PRESICA, Yaounde, Cameroon
[4] Inst Trop Med, Serv Sante Armee, Marseille, France
[5] Natl AIDS Control Program, Libreville, Gabon
[6] Innogenet, Ghent, Belgium
[7] CHU Gui Chaulhiac, Serv Malad Infect & Trop, Montpellier, France
关键词
HIV-1; subtypes; env; gag; recombination; AG-IBNG; Africa;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The genetic subtype was identified in gag and env of 219 HIV-l-positive samples collected in different African countries, 44 from Senegal, 55 from Cameroon, 82 from Gabon, and 38 from Djibouti. In total, 20 (9.1%) samples had discordant subtypes between gag and env, 6 of 44 (13.9%) in Senegal, 4 of 55 (7.2%) in Cameroon, 1 of 38 (2.6%) in Djibouti, and 10 of 82 (12.1%) in Gabon. Subtypes A and G were predominantly involved in the recombination events. Phylogenetic tree analysis of gag showed that an important number of the A sequences form a distinct subcluster with the AG-IBNG prototype strain (a complex A/G mosaic virus): 27 of 32 (84.3%) in Senegal, 12 of 17 (70.6%) in Nigeria, 24 of 39 (61.5%) in Cameroon, and 38 of 70 (54.3%) in Gabon. Full-length genome analysis of 3 and additional sequences in pol for 10 such strains confirmed that they have a similar complex A/G mosaic genomic structure. These data suggest that in West Africa, most probably between 60% and 84% of the subtype A viruses are recombinant AG-IBNG viruses. This finding has potential implications on future vaccine, diagnostic, and treatment strategies. The actual and future role of these viruses in the global pandemic must be monitored in all new molecular epidemiologic studies, a discrimination between subtype A and AG-IBNG-like viruses is necessary.
引用
收藏
页码:363 / 374
页数:12
相关论文
共 10 条
  • [1] Time-scale of minor HIV-1 complex circulating recombinant forms from Central and West Africa
    Edson Delatorre
    Gonzalo Bello
    BMC Evolutionary Biology, 16
  • [2] Time-scale of minor HIV-1 complex circulating recombinant forms from Central and West Africa
    Delatorre, Edson
    Bello, Gonzalo
    BMC EVOLUTIONARY BIOLOGY, 2016, 16
  • [3] CRF06-cpx: A new circulating recombinant form of HIV-1 in West Africa involving subtypes A, G, K, and J
    Montavon, C
    Toure-Kane, C
    Nkengasong, JN
    Vergne, L
    Hertogs, K
    Mboup, S
    Delaporte, E
    Peeters, M
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (05) : 522 - 530
  • [4] Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa
    Farinre, Omotayo
    Gounder, Kamini
    Reddy, Tarylee
    Tongo, Marcel
    Hare, Jonathan
    Chaplin, Beth
    Gilmour, Jill
    Kanki, Phyllis
    Mann, Jaclyn K.
    Ndung'u, Thumbi
    RETROVIROLOGY, 2021, 18 (01)
  • [5] Molecular characterization of non-subtype C and recombinant HIV-1 viruses from Cape Town, South Africa
    Wilkinson, Eduan
    Engelbrecht, Susan
    INFECTION GENETICS AND EVOLUTION, 2009, 9 (05) : 840 - 846
  • [6] DNA prime-protein boost using subtype consensus Env was effective in eliciting neutralizing antibody responses against subtype BC HIV-1 viruses circulating in China
    Zhang, Mingshun
    Zhang, Lu
    Zhang, Chunhua
    Hong, Kunxue
    Shao, Yiming
    Huang, Zuhu
    Wang, Shixia
    Lu, Shan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (11) : 1630 - 1637
  • [7] High Frequency of HIV-1 Dual Infections Among HIV-Positive Individuals in Cameroon, West Central Africa
    Powell, Rebecca L. R.
    Urbanski, Mateusz M.
    Burda, Sherri
    Kinge, Thompson
    Nyambi, Phillipe N.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (01) : 84 - 92
  • [8] In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in West and Central Africa
    Villabona-Arenas, Christian Julian
    Vidal, Nicole
    Guichet, Emilande
    Serrano, Laetitia
    Delaporte, Eric
    Gascuel, Olivier
    Peeters, Martine
    AIDS, 2016, 30 (17) : 2577 - 2589
  • [9] Phenotypic studies on recombinant human immunodeficiency virus type 1 (HIV-1) containing CRF01_AE env gene derived from HIV-1-infected patient, residing in central Thailand
    Utachee, Piraporn
    Jinnopat, Piyamat
    Isarangkura-na-ayuthaya, Panasda
    de Silva, U. Chandimal
    Nakamura, Shota
    Siripanyaphinyo, Uamporn
    Wichukchinda, Nuanjun
    Tokunaga, Kenzo
    Yasunaga, Teruo
    Sawanpanyalert, Pathom
    Ikuta, Kazuyoshi
    Auwanit, Wattana
    Kameoka, Masanori
    MICROBES AND INFECTION, 2009, 11 (03) : 334 - 343
  • [10] Human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and G
    Konings, FAJ
    Burda, ST
    Urbanski, MM
    Zhong, P
    Nadas, A
    Nyambi, PN
    JOURNAL OF MEDICAL VIROLOGY, 2006, 78 (05) : 523 - 534